ArticleInternational journal of ophthalmology2024

Comparison of inebilizumab or rituximab in addition to glucocorticoid therapy for neuromyelitis optica spectrum disorders.

Chu-Yuan Lou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.